ACADIA Pharmaceuticals Inc
ACAD
NASDAQ
Biotechnology
$28.24
USD
-0.14 (-0.49%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $4.89B
Volume 1.1M
Price Target
$30.00 – $41.00
USD
The 4 analysts offering 1-year price forecasts have a max estimate of $41.00 and a min estimate of $30.00.
Past 2Y
1Y Forecast
Price Targets
Average Target
$35.50
+$3.4 vs prior
Implied Upside
+25.7%
+12.0% vs prior
Analyst Covering
4
-5 vs prior period
Consensus
Buy
Improved vs prior
Signal Quality
Consensus Freshness
31%
Many ratings are older - consensus may be less current
Analyst Agreement
Moderate
Targets show moderate spread across analysts
Mean vs Median
$0 Gap
Median and average are closely aligned - few outliers skewing the consensus
Analyst Consensus
Strong Sell
Hold
Strong Buy
Buy
4 Buy
0 Hold
0 Sell
Rating Breakdown
Strong Buy
0
Buy
4
Hold
0
Sell
0
Strong Sell
0
4 analysts · last 3 months
Covering Analysts
Unlock each analyst's profile, success rate + price targets
Free shows the consensus and each analyst's current rating.
| Analyst | Firm | Rating | Action | Date | Success Rate | Price Target | Implied Upside |
|---|---|---|---|---|---|---|---|
Ami Fadia | Needham | Buy | Maintained | 3 days ago | Plus | Plus | Plus |
Tazeen Ahmad | B of A Securities | Buy | Maintained | 1 month ago | Plus | Plus | Plus |
Sumant Kulkarni | Canaccord Genuity | Buy | Maintained | 1 month ago | Plus | Plus | Plus |
Yigal Nochomovitz | Citigroup | Buy | Maintained | 1 month ago | Plus | Plus | Plus |
Frequently Asked Questions
Similar Stocks
